Explore more publications!

Press Releases

Medical Device Connectivity Market is expected to generate a revenue of USD 13.4 Billion by 2032, Globally, at 23.40% CAGR: Verified Market Research®
Guide highlights strategies for hospitals to manage mass violence incidents
La Gobernadora Hochul Presenta Nuevas Iniciativas para Fortalecer el Sistema de Atención Médica de Nueva York y Reducir los Costos Del Servicio

La Gobernadora Hochul Presenta Nuevas Iniciativas para Fortalecer el Sistema de Atención Médica de Nueva York y Reducir los Costos Del Servicio

Governor Abbott Reappoints Three To Texas State Board Of Veterinary Medical Examiners

Governor Abbott Reappoints Three To Texas State Board Of Veterinary Medical Examiners

California Medical Facility Officials Investigating the Death of an Incarcerated Person as a Homicide

California Medical Facility Officials Investigating the Death of an Incarcerated Person as a Homicide

Dempsey Kingsland & Osteen Expands Advocacy for Medical Negligence Victims
Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy
Health PEI asks for patience as hospitals face ongoing capacity pressures
Kaneka Medical America LLC Announces U.S. Launch of WaveSelect 1014 Guidewire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTA
Carr: Warner Robins Woman Convicted of Defrauding Georgia Medicaid of $5.4 Million

Carr: Warner Robins Woman Convicted of Defrauding Georgia Medicaid of $5.4 Million

FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications

FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform
Conavi Medical Corp. Announces Closing of $12M Public Offering
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease
RCP welcomes announcement of Bill to prioritise UK medical graduates for training places

RCP welcomes announcement of Bill to prioritise UK medical graduates for training places

Traws Pharma Files Tivoxavir Marboxil Investigational New Drug (IND) Application for Influenza Therapy, and Provides Updated Results from the Ongoing Clinical Study of Ratutrelvir in PAXLOVID®-Eligible and Ineligible COVID-19 Patients

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions